Kaylie Sylvester, | |
200 Forest St, Mccall, ID 83638-5256 | |
(208) 630-2470 | |
Not Available |
Full Name | Kaylie Sylvester |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 6 Years |
Location | 200 Forest St, Mccall, Idaho |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497310411 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Mccall | Mccall, ID | Hospital |
St Luke's Regional Medical Center | Boise, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Lukes Clinic - Mccall Llc | 7618127994 | 39 |
News Archive
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center investigators.
Columbia University scientists have developed a computational method to investigate the relationship between birth month and disease risk.
To respond to the spread of the new coronavirus, public health authorities need to know who's getting sick. Now, a new app, developed through an unusual partnership, empowers nearly anyone in the United States to share their health status.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Kaylie Sylvester, 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Kaylie Sylvester, 200 Forest St, Mccall, ID 83638-5256 Ph: (208) 630-2470 |
News Archive
Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center investigators.
Columbia University scientists have developed a computational method to investigate the relationship between birth month and disease risk.
To respond to the spread of the new coronavirus, public health authorities need to know who's getting sick. Now, a new app, developed through an unusual partnership, empowers nearly anyone in the United States to share their health status.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy.
› Verified 4 days ago